RecruitingNot ApplicableNCT07523477

Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis

Evaluation of Local Injection of Botulinium Toxin-A in Children With Dysfunctional Voiding or Refractory Nocturnal Eneuresis


Sponsor

Tanta University

Enrollment

64 participants

Start Date

Jun 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to evaluate the outcome of botulinum toxin A (BTX-A) injection for management of children with : A-Dysfunctional voiding who are not responding to traditional treatment. B-Refractory nocturnal enuresis.


Eligibility

Max Age: 18 Years

Inclusion Criteria3

  • Children < 18 years.
  • Both sexes.
  • Patients with refractory nocturnal enuresis or dysfunctional voiding who are not responding to the traditional treatment.

Exclusion Criteria4

  • Bleeding disorders.
  • Neuromusclar disorder(e.g.,Myasthenia gravis).
  • Patients who are not fit for anaesthesia.
  • Active urinary tract infection (UTI).

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGBotulinium Toxin-A

Patients will be injected with botulinium toxin-A


Locations(1)

Tanta University

Tanta, El-Gharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07523477


Related Trials